丁丙诺啡诱导尝试次数影响母婴结局:一项多中心队列研究
这项多中心回顾性队列研究纳入2018年6月18日至2021年1月1日在3个三级医疗中心接受舌下丁丙诺啡诱导治疗阿片类物质使用障碍的63例孕妇,比较仅需1次诱导尝试者(38例,60.3%)与需多次尝试但最终成功者(25例,39.7%)。多次尝试与分娩时非处方阿片类使用、早产风险升高及母乳喂养率降低相关。
要点
- 多次丁丙诺啡诱导尝试与分娩时非处方阿片类使用风险显著升高相关(76.0% vs 15.8%,校正OR 30.00)。
- 多次诱导尝试者早产风险升高(48.0% vs 15.8%,校正HR 3.24)。
- 多次诱导尝试者母亲出院和婴儿出院时母乳喂养率均降低。
核心结论
- 需要多次丁丙诺啡诱导尝试显著增加分娩时非处方阿片类使用的比值和早产风险,并降低母乳喂养的比值。
- 作者认为,由于丁丙诺啡诱导过程可能影响孕期诱导患者的产科结局,亟需研究提高诱导成功可能性的技术以改善母婴阿片类使用障碍患者的结局。
研究设计与样本
- 多中心回顾性队列研究,纳入2018年6月18日至2021年1月1日在3个三级医疗中心接受舌下丁丙诺啡诱导治疗阿片类使用障碍的所有孕妇。
- 比较仅需1次诱导尝试成功者(38例,60.3%)与需多次尝试但最终在孕期成功启动治疗者(25例,39.7%),治疗启动经尿液药物筛查确认。
- 主要结局为分娩时非处方阿片类使用;次要结局包括与阿片类使用障碍相关的产科和新生儿结局。
- 背景特征采用Fisher精确检验、卡方检验、Mann-Whitney U检验和Student t检验比较;结局采用多变量logistic回归比较;启动产前保健至分娩时间采用Kaplan-Meier曲线和Cox比例风险模型比较。
主要发现
- 共纳入63例孕期接受丁丙诺啡诱导的患者,1次尝试组38例(60.3%),多次尝试组25例(39.7%)。
- 两组背景特征无统计学差异。
- 多次诱导尝试组分娩时非处方阿片类使用率为76.0%,1次尝试组为15.8%,校正OR 30.00(95%CI 5.50-163.90)。
- 多次诱导尝试组早产率为48.0%,1次尝试组为15.8%,校正HR 3.24(95%CI 1.17-8.95)。
- 多次诱导尝试组母亲出院时母乳喂养率为24.0%,1次尝试组为78.9%,校正OR 0.06(95%CI 0.00-0.30);婴儿出院时母乳喂养率分别为24.0% vs 55.3%,校正OR 0.23(95%CI 0.10-0.80)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Buprenorphine can be used to treat maternal opioid use disorder effectively and decrease obstetrical risks. Compared with the use of other medications to treat opioid use disorder, the use of buprenorphine results in improved neonatal outcomes; however, its use is associated with higher rates of treatment attrition. Initiation of buprenorphine, termed "induction," is a high-risk time for treatment dropout and can require repeated attempts. OBJECTIVE: This study aimed to evaluate the effect of multiple buprenorphine induction attempts on maternal and neonatal outcomes. STUDY DESIGN: This was a retrospective cohort study of all pregnant patients who underwent sublingual buprenorphine induction for the treatment of opioid use disorder from June 18, 2018, to January 1, 2021, at 3 tertiary care centers. Patients who required only 1 attempt for successful buprenorphine induction were compared with those who required multiple attempts but ultimately were successful in the treatment initiation during pregnancy, confirmed by urine drug screening. The primary outcome was nonprescribed opioid use at the time of delivery. The secondary outcomes included obstetrical and neonatal outcomes associated with opioid use disorder. Background characteristics were compared using Fisher exact, chi-square, Mann-Whitney U, and Student t tests. The outcomes were compared using multivariable logistic regression, and time to delivery after initiation of prenatal care was compared between groups using Kaplan-Meier curves and a Cox proportional-hazards model. RESULTS: Overall, 63 patients undergoing buprenorphine induction during pregnancy were included, with 38 (60.3%) patients with 1 attempt and 25 patients (39.7%) with multiple attempts. There was no statistical difference between the 2 groups in terms of background characteristics. Compared with a single successful attempt, multiple attempts at buprenorphine induction were associated with a significantly increased odds of nonprescribed opioid use at the time of delivery (76.0% vs 15.8%; adjusted odds ratio, 30.00; 95% confidence interval, 5.50-163.90), increased risk of preterm birth (48.0% vs 15.8%; adjusted hazard ratio, 3.24; 95% confidence interval, 1.17-8.95), and decreased rate of breastfeeding at both maternal discharge (24.0% vs 78.9%; adjusted odds ratio, 0.06; 95% confidence interval, 0.00-0.30) and infant discharge (24.0% vs 55.3%; adjusted odds ratio, 0.23; 95% confidence interval, 0.10-0.80). CONCLUSION: Requiring multiple attempts for buprenorphine induction significantly increases the odds of nonprescribed opioid use at the time of delivery and preterm birth and decreases the odds of breastfeeding. As the buprenorphine induction process may affect obstetrical outcomes for patients induced during pregnancy, investigating the techniques that increase the likelihood of successful induction is crucially needed to improve outcomes in patients with maternal opioid use disorder.
引用
- Kelly JC, Ayala NK, Holroyd L, et al. Number of buprenorphine induction attempts impacts maternal and neonatal outcomes: a multicenter cohort study. Am J Obstet Gynecol MFM. 2023. PMID: 38236700. doi:10.1016/j.ajogmf.2023.100998
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。